OmniActive Health Technologies have announced positive results from the Phase 1 acute effects of Alpinia galanga extract on mental alertness, accuracy, and fatigue study.
The study's primary objective was to evaluate the efficacy of using a caffeine-alternative energy nootropic, Alpinia galanga extract or enXtra, on mental alertness and fatigue in healthy adults. It was published in Advances in Complementary & Alternative Medicine.
This randomised, double-blind, placebo-controlled cross-over study involved 62 subjects who consumed a 300 mg/d single serving of enXtra. The study showed that enXtra supplementation improved alertness, reaction time, and correct responses, reducing errors. Some results, such as the number of correct responses measured by the Symbol Digit Coding test at 30 minutes, were about three times greater with enXtra supplementation.
Similarly, fatigue scores, which were measured about 5 to 6 hours post-supplementation with enXtra, were reduced versus baseline and placebo. Alertness, measured by the alertness rating scale, showed about a four-fold greater change at two hours versus the placebo, and simple reaction time, measured by the Stroop Test, lasted up to 5 hours post-dosing.
"We are pleased that this study validates our previous clinical findings of enXtra. The data supports its relevance as an effective and safe alternative to caffeine for companies looking to provide natural nootropics to support mental alertness, focus, and attention without impacting energy level," said Deshanie Rai, PhD, FACN, VP, Global Scientific, and Regulatory Affairs at OmniActive.
The CNS vital signs battery of computerised tests, a widely used and validated method, measured nootropic benefits at baseline, 0.5, 1-, 2- and 5 hours post-dose. The visual analogue scale and daytime sleepiness by Epworth sleepiness scales measured the subjects' fatigue and energy levels.
"Health-conscious consumers are looking for ways to manage their mental energy for optimal performance through caffeine-free products with little to no side effects," said Adam Adelmann, Chief Commercial Officer at OmniActive." This study supports that our enXtra ingredient can do this, and we are excited to share it with our partners. As the energy ingredients market grows, enXtra can be a game-changer for those looking to bring more natural energy solutions to market."
enXtra is formulated from a proprietary extract of DNA-authenticated Alpinia galanga, or Thai ginger, and is well suited for manufacturers of energy drinks, RTDs, shots, bars, gummies, stick packs, and more.